These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2967093)
21. Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug. Severson JA; Robinson HE; Simpson GM Psychopharmacology (Berl); 1984; 84(1):115-9. PubMed ID: 6149590 [TBL] [Abstract][Full Text] [Related]
22. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Wilmot CA; Szczepanik AM Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063 [TBL] [Abstract][Full Text] [Related]
23. Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography. Bahn MM; Huang SC; Hawkins RA; Satyamurthy N; Hoffman JM; Barrio JR; Mazziotta JC; Phelps ME J Cereb Blood Flow Metab; 1989 Dec; 9(6):840-9. PubMed ID: 2531147 [TBL] [Abstract][Full Text] [Related]
24. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride. Yokoi F; Gründer G; Biziere K; Stephane M; Dogan AS; Dannals RF; Ravert H; Suri A; Bramer S; Wong DF Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598 [TBL] [Abstract][Full Text] [Related]
26. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol. Tauscher J; Küfferle B; Asenbaum S; Fischer P; Pezawas L; Barnas C; Tauscher-Wisniewski S; Brücke T; Kasper S Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042 [TBL] [Abstract][Full Text] [Related]
27. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone. Nordström AL; Farde L; Eriksson L; Halldin C Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390 [TBL] [Abstract][Full Text] [Related]
28. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation. Korf J; Sebens JB J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979 [TBL] [Abstract][Full Text] [Related]
29. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis. Zipursky RB; Christensen BK; Daskalakis Z; Epstein I; Roy P; Furimsky I; Sanger T; Kapur S Can J Psychiatry; 2005 Jul; 50(8):462-9. PubMed ID: 16127964 [TBL] [Abstract][Full Text] [Related]
30. Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings. Nyberg S; Farde L; Halldin C Arch Gen Psychiatry; 1997 Oct; 54(10):953-8. PubMed ID: 9337776 [TBL] [Abstract][Full Text] [Related]
31. Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Baron JC; Martinot JL; Cambon H; Boulenger JP; Poirier MF; Caillard V; Blin J; Huret JD; Loc'h C; Maziere B Psychopharmacology (Berl); 1989; 99(4):463-72. PubMed ID: 2574481 [TBL] [Abstract][Full Text] [Related]
32. In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans. Cambon H; Baron JC; Boulenger JP; Loc'h C; Zarifian E; Maziere B Br J Psychiatry; 1987 Dec; 151():824-30. PubMed ID: 2901886 [TBL] [Abstract][Full Text] [Related]
33. Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine. Kapur S; Roy P; Daskalakis J; Remington G; Zipursky R Am J Psychiatry; 2001 Feb; 158(2):311-4. PubMed ID: 11156818 [TBL] [Abstract][Full Text] [Related]
34. Amphetamine induced decreases in (18F)-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Dewey SL; Logan J; Wolf AP; Brodie JD; Angrist B; Fowler JS; Volkow ND Synapse; 1991 Apr; 7(4):324-7. PubMed ID: 2042113 [No Abstract] [Full Text] [Related]
35. Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade. Fitzgerald PB; Kapur S; Caligiuri MP; Jones C; Silvestri S; Remington G; Zipursky RB Neuropsychopharmacology; 2000 Jan; 22(1):19-26. PubMed ID: 10633487 [TBL] [Abstract][Full Text] [Related]
36. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning. Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341 [TBL] [Abstract][Full Text] [Related]
37. Striatal D2-dopamine receptor occupancy during treatment with typical and atypical neuroleptics. Scherer J; Tatsch K; Schwarz J; Oertel W; Kirsch MC; Albus M Biol Psychiatry; 1994 Nov; 36(9):627-9. PubMed ID: 7833430 [No Abstract] [Full Text] [Related]
38. Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas. Vernaleken I; Janouschek H; Raptis M; Hellmann S; Veselinovic T; Bröcheler A; Boy C; Cumming P; Hiemke C; Rösch F; Schäfer WM; Gründer G Int J Neuropsychopharmacol; 2010 Aug; 13(7):951-60. PubMed ID: 20392299 [TBL] [Abstract][Full Text] [Related]
39. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography. Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148 [TBL] [Abstract][Full Text] [Related]
40. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Kapur S; Zipursky R; Jones C; Remington G; Houle S Am J Psychiatry; 2000 Apr; 157(4):514-20. PubMed ID: 10739409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]